These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 33583902

  • 21. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D, Nadkar M, Rajadhyaksha A, Pandit-Shende P, Surve P, Dawkar N, Khadilkar P, Patwardhan M, Kaveri S, Ghosh K, Pradhan V.
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T, Cetin E, Kaşifoğlu N, Kaşifoğlu T, Akgün Y.
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [Abstract] [Full Text] [Related]

  • 26. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
    Kojima M, Motoori T, Asano S, Nakamura S.
    Pathol Res Pract; 2007 Oct; 203(6):423-31. PubMed ID: 17540509
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D, Kuskucu MA, Sahin S, Adrovic A, Barut K, Yıldız M, Sharifova S, Midilli K, Cokugras H, Camcıoglu Y, Kasapcopur O.
    Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
    Daroontum T, Kohno K, Inaguma Y, Okamoto A, Okamoto M, Kimura Y, Nagahama M, Sakakibara A, Satou A, Nakamura S.
    Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
    [Abstract] [Full Text] [Related]

  • 29. Clinical features of NK/T-cell EBV-associated LPD manifested as gastrointestinal symptoms in patients with normal immunity: a case report and literature review.
    Wang SZ, Dai YH, Zhang J, Lu FG, Yan LM, Wu S.
    BMC Gastroenterol; 2021 Jun 10; 21(1):254. PubMed ID: 34112087
    [Abstract] [Full Text] [Related]

  • 30. Case of primary intraocular lymphoproliferative disorder caused by Epstein-Barr Virus.
    Ban Y, Okamoto M, Ogata N.
    BMC Ophthalmol; 2020 Jul 28; 20(1):306. PubMed ID: 32723308
    [Abstract] [Full Text] [Related]

  • 31. Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.
    Wada S, Suzuki T, Kitazume K, Fujita A, Shimizu S.
    Int J Hematol; 2018 Jul 28; 108(1):112-117. PubMed ID: 29218495
    [Abstract] [Full Text] [Related]

  • 32. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
    Satou A, Tabata T, Suzuki Y, Sato Y, Tahara I, Mochizuki K, Oishi N, Takahara T, Yoshino T, Tsuzuki T, Nakamura S.
    Virchows Arch; 2021 May 28; 478(5):969-976. PubMed ID: 33169195
    [Abstract] [Full Text] [Related]

  • 33. [Epstein-Barr virus-associated lymphoproliferative disorders after BNT162b2 mRNA COVID-19 vaccination].
    Tanaka A, Kawaguchi T, Imadome KI, Hara S.
    Rinsho Ketsueki; 2023 May 28; 64(4):277-282. PubMed ID: 37121772
    [Abstract] [Full Text] [Related]

  • 34. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
    Nomura M, Sumiya R, Ono H, Nagai T, Kumazawa K, Shimizu A, Endo D, Aoyanagi N.
    World J Surg Oncol; 2021 Jan 02; 19(1):4. PubMed ID: 33388058
    [Abstract] [Full Text] [Related]

  • 35. A case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder.
    Cho HS, Kim IS, Park HC, Ahn MJ, Lee YY, Park CK.
    Korean J Intern Med; 2004 Jun 02; 19(2):124-7. PubMed ID: 15366645
    [Abstract] [Full Text] [Related]

  • 36. Primary Intestinal Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease.
    Wang Z, Zhang W, Luo C, Zhu M, Zhen Y, Mu J, Zhang Y, Hu R, Wang Y, Wen Z, Ouyang Q, Xiao S, Zhang H.
    J Crohns Colitis; 2018 Jul 30; 12(8):896-904. PubMed ID: 29635312
    [Abstract] [Full Text] [Related]

  • 37. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection.
    Dror Y, Blachar Y, Cohen P, Livni N, Rosenmann E, Ashkenazi A.
    Am J Kidney Dis; 1998 Nov 30; 32(5):825-8. PubMed ID: 9820454
    [Abstract] [Full Text] [Related]

  • 38. Systematic Epstein-Barr virus-positive T-cell lymphoproliferative disease presenting as a persistent fever and cough: a case report.
    Ameli F, Ghafourian F, Masir N.
    J Med Case Rep; 2014 Aug 27; 8():288. PubMed ID: 25163591
    [Abstract] [Full Text] [Related]

  • 39. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
    Arai A.
    Rinsho Ketsueki; 2023 Aug 27; 64(8):764-771. PubMed ID: 37673629
    [Abstract] [Full Text] [Related]

  • 40. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
    Chapman J.
    Surg Pathol Clin; 2023 Jun 27; 16(2):213-231. PubMed ID: 37149357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.